Mouse models demonstrate that engraftment of NHL directly correlates with tumor VEGF production, and targeting the VEGF pathway with neutralizing antibodies results in inhibition of tumor growth [137,138]. This evidence concerns the gene VEGFA and non-Hodgkin lymphoma.